Related Experiment Video
Updated: Oct 5, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis
1Department of Food and Nutrition, Faculty of Home Economics, Kyoto Women's University, 35 Imakumanokitahiyoshicyo, Kyoto 605-8501, Japan.
Abstract:
Prevention of atherosclerosis is important because it is a risk factor for cardiovascular diseases globally. One of the causes of atherosclerosis is accumulation of cholesterol and triglycerides in peripheral cells. ATP-binding cassette protein A1 (ABCA1) and G1 (ABCG1) are important in eliminating excess cholesterol from cells including macrophages and forming high-density lipoprotein, which contributes to the prevention and regression of atherosclerosis. Enhanced cholesterol efflux activities of ABCA1 and ABCG1 are expected to prevent the progression of atherosclerosis. ABCA1 and ABCG1 are induced by the LXR/RXR pathway and regulated transcriptionally, post-transcriptionally, and post-translationally. Their mRNAs are destabilized by microRNAs and their cellular localization and degradation are regulated by other proteins and phosphorylation. Furthermore, ABCA1 and ABCG1 suppress the inflammatory responses of macrophages. These proteins are effective targets because their increased activities can suppress cholesterol accumulation and inflammation in macrophages. Moreover, ABCA1 and ABCG1 prevent amyloid β accumulation; therefore, their increased activity may prevent Alzheimer's disease. Because ABCA1 and ABCG1 are affected by transcriptional, post-transcriptional, and post-translational regulation, the regulatory factors involved could also serve as therapeutic targets. This review highlights that ABCA1 and ABCG1 could be potential therapeutic targets for preventing atherosclerosis by regulating their expression, degradation, and localization.
Insights
Targeting ATP-binding cassette proteins A1 (ABCA1) and G1 (ABCG1) can prevent atherosclerosis. Enhancing their cholesterol efflux and anti-inflammatory activities offers a therapeutic strategy for cardiovascular and neurodegenerative diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Atherosclerosis, a major global cardiovascular disease risk factor, stems from cellular cholesterol accumulation.
- ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1) are crucial for reverse cholesterol transport and high-density lipoprotein formation.
- Dysregulation of ABCA1 and ABCG1 contributes to atherosclerosis progression and associated inflammatory processes.
Purpose of the Study:
- To review the regulatory mechanisms of ABCA1 and ABCG1.
- To highlight the therapeutic potential of modulating ABCA1 and ABCG1 for atherosclerosis prevention.
- To explore the role of ABCA1 and ABCG1 in preventing other conditions like Alzheimer's disease.
Main Methods:
- Literature review of studies on ABCA1 and ABCG1 function and regulation.
- Analysis of transcriptional, post-transcriptional, and post-translational control mechanisms.
- Examination of the impact of ABCA1 and ABCG1 on cholesterol efflux and inflammation.
Main Results:
- ABCA1 and ABCG1 expression and activity are tightly regulated at multiple levels.
- Enhanced ABCA1 and ABCG1 function effectively reduce cellular cholesterol and suppress macrophage inflammation.
- ABCA1 and ABCG1 also play a role in preventing amyloid-beta accumulation, suggesting broader therapeutic applications.
Conclusions:
- ABCA1 and ABCG1 are promising therapeutic targets for atherosclerosis.
- Modulating the expression, degradation, and localization of ABCA1 and ABCG1 can prevent cholesterol buildup and inflammation.
- Targeting ABCA1 and ABCG1 pathways may offer novel strategies for treating cardiovascular and neurodegenerative diseases.
Related Concept Videos
Atherosclerosis III: Management
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
ABC Transporters: Exporter
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction

